Tracking this diagnosis for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanC81.0A
BillableNodular lymphocyte predominant Hodgkin lymphoma, in remission
C81.0A is the ICD-10-CM code for Nodular lymphocyte predominant Hodgkin lymphoma, in remission. It is a billable, specific code valid for reimbursement.
C00-D49 Neoplasms
Medications indicated for this condition
FDA labeling- Doxorubicin›
- CarmustineAlkylating Drug [EPC]›
- CyclophosphamideAlkylating Drug [EPC]›
- LomustineAlkylating Drug [EPC]›
- Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol›
- Betamethasone Sodium Phosphate and Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine›
- Bleomycin›
- Brentuximab VedotinCD30-directed Immunoconjugate [EPC]›
- ChlorambucilAlkylating Drug [EPC]›
- Cyclophosphamide for Injection›
- DacarbazineAlkylating Drug [EPC]›
- Gallium›
Drugs whose FDA labeling lists this condition's category among its indications. Informational only — not a treatment recommendation or medical advice.
Conditions mapped to this code
MedlinePlus · NIHPlain-language health-topic references grounded in MedlinePlus (NIH/NLM).
Frequently asked questions
Source: CMS ICD-10-CM FY2026. For informational purposes only — not medical advice. See our medical disclaimer.
Look up another ICD-10 code or condition